Tumor Immunology

Branch of  biology concerned with the part of the vulnerable system in the progression and development of cancer is known as Tumor Immunology. The most well know operation is Cancer Immune remedy whereas vulnerable system is used to treat cancer. It also be suggested that Immunosurveillance primarily functions as an element of a more general process of cancer immunoediting.

Immunoediting induces selection for certain excrescence cells, which loose dominant excrescence-specific antigens allowing the excrescence to progress. It has 3 main phases elimination, equilibrium and escape.

  • Carcinogenesis
  • Onco-genomics
  • Cancer Immunology & Immunotherapy
  • Cancer therapeutic resistance
  • Antitumor Effector Cells and Regulation of Tumor Immunity
  • Tumor-Associated Antigen & Immunosuppression
  • Mechanisms of Tumor Rejection and Modulation of Antitumor Responses
  • Pathobiology of Immune System Malignancies
  • Chemotherapy, Radiotherapy & Targeted therapies
  • Drug Development & Vaccines
  • Treatment Approaches for Cancer
  • Specific / Non-specific Immunotherapies
  • Immuno-Oncology studies

    Related Conference of Tumor Immunology

    September 22-23, 2025

    6th World Congress on Neuroimmunology and Neuroinfectious Diseases

    Amsterdam, Netherlands
    October 16-17, 2025

    39th International Conference on Immunology

    Amsterdam, Netherlands
    May 18-19, 2026

    17th Global Summit on Immunology and Cell Biology

    Paris, Aland Islands

    Tumor Immunology Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in